Pediatric Stroke: Causes and Management

Professor of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Director, Stroke Program, Northwestern Memorial Hospital, Chicago, Illinois

Disclosure: Mark J. Alberts, MD, has disclosed the following relevant financial relationships:
Received honoraria from: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; diaDexus, Inc.; EKR Therapeutics Inc.; Genentech, Inc.; Medscape LLC; Pfizer Inc.; sanofi-aventis; Schering-Plough Corporation; The Medicines Company
Received grants for clinical research from: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EKR Therapeutics Inc.; Genentech, Inc.; PhotoThera; sanofi-aventis; Schering-Plough Corporation
Served as an advisor or consultant for: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EKR Therapeutics Inc.; Genentech, Inc.; Pfizer Inc.; sanofi-aventis; Takeda Pharmaceuticals North America, Inc.; The Medicines Company
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; diaDexus, Inc.; EKR Therapeutics Inc.; Genentech, Inc.; Medscape LLC; sanofi-aventis; The Medicines Company